Dr. Schwartz answers the question: 'Difference between in situ breast cancers?' — -- Question: What is the difference between ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS)?

While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...

Lobular breast cancer patients gathered at Fred Hutch Cancer Center last week for a two-hour program featuring patient stories, epidemiological findings and new developments in screening and clinical ...

Dr. Melvin Silverstein answers the question: 'What's Invasive Ductal Carcinoma?' — -- Question: What is invasive ductal carcinoma? Answer: Invasive ductal carcinoma is the most common type of ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...

While researchers work to improve lobular breast cancer screening, innovative treatments are improving outcomes for patients with the condition, which is diagnosed in more than 40,000 Americans each ...

ILC makes up 10–15% of all invasive breast cancers but often goes underdiagnosed due to its diffuse growth pattern. The hallmark of ILC is the loss of E-cadherin, leading to its characteristic ...

The Breast International Group (BIG) 1-98 study evaluated adjuvant endocrine therapy in postmenopausal women who had hormone receptor-positive early-stage breast cancer. The study participants were ...

Delayed musculoskeletal symptoms after breast radiotherapy can reflect osteoradionecrosis rather than recurrence, thus ...

Please provide your email address to receive an email when new articles are posted on . Lobular breast cancer would be the seventh most common malignancy among women in the U.S. if ranked separately ...